COVID-19 vaccines elicit robust cellular immunity and clinical protection in chronic lymphocytic leukemia
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:40 |
|---|---|
| Enthalten in: |
Cancer cell - 40(2022), 6 vom: 13. Juni, Seite 584-586 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Parry, Helen [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 16.06.2022 Date Revised 13.06.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.ccell.2022.05.001 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM341114758 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM341114758 | ||
| 003 | DE-627 | ||
| 005 | 20231226011031.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ccell.2022.05.001 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1137.xml |
| 035 | |a (DE-627)NLM341114758 | ||
| 035 | |a (NLM)35588735 | ||
| 035 | |a (PII)S1535-6108(22)00212-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Parry, Helen |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a COVID-19 vaccines elicit robust cellular immunity and clinical protection in chronic lymphocytic leukemia |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 16.06.2022 | ||
| 500 | |a Date Revised 13.06.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 700 | 1 | |a Bruton, Rachel |e verfasserin |4 aut | |
| 700 | 1 | |a Roberts, Thomas |e verfasserin |4 aut | |
| 700 | 1 | |a McIlroy, Graham |e verfasserin |4 aut | |
| 700 | 1 | |a Damery, Sarah |e verfasserin |4 aut | |
| 700 | 1 | |a Sylla, Panagiota |e verfasserin |4 aut | |
| 700 | 1 | |a Dowell, Alexander C |e verfasserin |4 aut | |
| 700 | 1 | |a Tut, Gokhan |e verfasserin |4 aut | |
| 700 | 1 | |a Lancaster, Tara |e verfasserin |4 aut | |
| 700 | 1 | |a Bone, David |e verfasserin |4 aut | |
| 700 | 1 | |a Willett, Brian |e verfasserin |4 aut | |
| 700 | 1 | |a Logan, Nicola |e verfasserin |4 aut | |
| 700 | 1 | |a Scott, Sam |e verfasserin |4 aut | |
| 700 | 1 | |a Hulme, Sam |e verfasserin |4 aut | |
| 700 | 1 | |a Jadir, Azar |e verfasserin |4 aut | |
| 700 | 1 | |a Amin, Umayr |e verfasserin |4 aut | |
| 700 | 1 | |a Nicol, Sam |e verfasserin |4 aut | |
| 700 | 1 | |a Stephens, Christine |e verfasserin |4 aut | |
| 700 | 1 | |a Faustini, Sian |e verfasserin |4 aut | |
| 700 | 1 | |a Al-Taei, Saly |e verfasserin |4 aut | |
| 700 | 1 | |a Richter, Alex |e verfasserin |4 aut | |
| 700 | 1 | |a Blakeway, Daniel |e verfasserin |4 aut | |
| 700 | 1 | |a Verma, Kriti |e verfasserin |4 aut | |
| 700 | 1 | |a Margielewska-Davies, Sandra |e verfasserin |4 aut | |
| 700 | 1 | |a Pearce, Hayden |e verfasserin |4 aut | |
| 700 | 1 | |a Pratt, Guy |e verfasserin |4 aut | |
| 700 | 1 | |a Zuo, Jianmin |e verfasserin |4 aut | |
| 700 | 1 | |a Paneesha, Shankara |e verfasserin |4 aut | |
| 700 | 1 | |a Moss, Paul |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancer cell |d 2002 |g 40(2022), 6 vom: 13. Juni, Seite 584-586 |w (DE-627)NLM119589826 |x 1878-3686 |7 nnns |
| 773 | 1 | 8 | |g volume:40 |g year:2022 |g number:6 |g day:13 |g month:06 |g pages:584-586 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ccell.2022.05.001 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 40 |j 2022 |e 6 |b 13 |c 06 |h 584-586 | ||